Trinity Bio ADR (TRIB)

$0.83 +0.01 (0.67%)
Market Cap 6.25M
Revenue (ttm) 56.83M
Net Income (ttm) -24.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -42.27%
Debt to Equity Ratio -2.52
Volume 143,300
Avg Vol 181,174
Day's Range N/A - N/A
Shares Out 7.62M
Stochastic %K 17%
Beta 1.01
Analysts Strong Buy
Price Target $15.00

Latest News on TRIB

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Dec 24, 2024, 8:33 AM EST - 24 days ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Dec 18, 2024, 11:00 AM EST - 4 weeks ago

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 12:37 PM EST - 2 months ago

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 9:00 AM EST - 2 months ago

Trinity Biotech Announces Q3 2024 Financial Results

Trinity Biotech to Announce Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 2 months ago

Trinity Biotech to Announce Q3 2024 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Nov 7, 2024, 8:19 AM EST - 2 months ago

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Oct 25, 2024, 8:45 AM EDT - 3 months ago

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Oct 25, 2024, 8:45 AM EDT - 3 months ago

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Oct 7, 2024, 8:15 AM EDT - 3 months ago

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Sep 24, 2024, 4:05 PM EDT - 4 months ago

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Sep 18, 2024, 4:05 PM EDT - 4 months ago

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Sep 9, 2024, 4:05 PM EDT - 4 months ago

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Sep 3, 2024, 9:55 AM EDT - 4 months ago

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Aug 26, 2024, 4:05 PM EDT - 5 months ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Aug 20, 2024, 5:00 PM EDT - 5 months ago

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 3:43 AM EDT - 5 months ago

Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript

Trinity Biotech Announces Q2 2024 Financial Results

Aug 14, 2024, 7:30 AM EDT - 5 months ago

Trinity Biotech Announces Q2 2024 Financial Results

Trinity Biotech to Announce Q2 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 5 months ago

Trinity Biotech to Announce Q2 2024 Financial Results

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Aug 6, 2024, 4:05 PM EDT - 5 months ago

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Aug 2, 2024, 9:24 AM EDT - 6 months ago

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Trinity Biotech Announces Appointment of A New CFO

Jul 9, 2024, 4:05 PM EDT - 6 months ago

Trinity Biotech Announces Appointment of A New CFO

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

Jun 24, 2024, 7:00 AM EDT - 7 months ago

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

Jun 10, 2024, 9:10 AM EDT - 7 months ago

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

Jun 3, 2024, 4:00 AM EDT - 8 months ago

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript

May 23, 2024, 6:44 PM EDT - 8 months ago

Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

May 23, 2024, 8:00 AM EDT - 8 months ago

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

Trinity Biotech plc to Announce Q1 2024 Financial Results

May 21, 2024, 4:05 PM EDT - 8 months ago

Trinity Biotech plc to Announce Q1 2024 Financial Results

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

May 16, 2024, 9:18 AM EDT - 8 months ago

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

May 13, 2024, 11:42 AM EDT - 8 months ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

May 8, 2024, 10:36 AM EDT - 9 months ago

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 3:03 PM EDT - 10 months ago

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Apr 4, 2024, 7:30 AM EDT - 10 months ago

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Mar 28, 2024, 6:39 PM EDT - 10 months ago

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Mar 8, 2024, 10:03 AM EST - 11 months ago

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Feb 15, 2024, 12:34 PM EST - 1 year ago

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Feb 13, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Trinity Biotech to Present at Emerging Growth Conference

Feb 8, 2024, 8:30 AM EST - 1 year ago

Trinity Biotech to Present at Emerging Growth Conference

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Feb 7, 2024, 8:30 AM EST - 1 year ago

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)

Jan 31, 2024, 5:14 PM EST - 1 year ago

Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

Jan 31, 2024, 7:05 AM EST - 1 year ago

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Jan 31, 2024, 7:02 AM EST - 1 year ago

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

Jan 31, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

Trinity Biotech plc to Host Investor Call

Jan 30, 2024, 5:23 PM EST - 1 year ago

Trinity Biotech plc to Host Investor Call

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

Dec 27, 2023, 8:57 AM EST - 1 year ago

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

Trinity Biotech Announces Management Changes

Dec 18, 2023, 4:30 PM EST - 1 year ago

Trinity Biotech Announces Management Changes

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Nov 28, 2023, 4:05 PM EST - 1 year ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Trinity Biotech plc (TRIB) Q2 2023 Earnings Call Transcript

Oct 3, 2023, 2:41 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q2 2023 Earnings Call Transcript

Trinity Biotech Announces Q2 2023 Financial Results

Oct 3, 2023, 9:15 AM EDT - 1 year ago

Trinity Biotech Announces Q2 2023 Financial Results

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

Sep 27, 2023, 12:50 PM EDT - 1 year ago

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

Sep 11, 2023, 4:50 PM EDT - 1 year ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement